Comparative studies of inhaled corticosteroids in asthma.

With inhaled corticosteroids being the mainstay of anti-inflammatory treatment in asthma, it is necessary to determine the comparative efficacy and safety of different corticosteroids delivered through different inhaler devices. Over recent years this has assumed considerable importance, with the phasing out of metered dose inhalers using chlorofluorocarbon (CFC) propellants, and with the availability of an increasing number of different dry powder devices or aerosol metered dose inhalers in which alternative hydrofluoroalkane (HFA) propellants have been used. This has led to numerous studies in which the efficacy of inhaled corticosteroid preparations, either dry powder or HFA- containing aerosol metered dose inhalers, have been compared with the same or different inhaled corticosteroids via standard CFC-containing preparations in current use. Although numerous study designs are available for such comparisons, that most commonly employed has been single high dose comparisons, with the lack of statistical significant differences between the two preparations being proposed to indicate …

[1]  L. Edwards,et al.  Low-dose inhaled fluticasone propionate versus oral zafirlukast in the treatment of persistent asthma. , 2000, The Journal of allergy and clinical immunology.

[2]  R. Hubbard,et al.  Inhaled corticosteroid use and bone-mineral density in patients with asthma , 2000, The Lancet.

[3]  B. Lipworth,et al.  Dose-response evaluation of the therapeutic index for inhaled budesonide in patients with mild-to-moderate asthma. , 2000, The American journal of medicine.

[4]  W. Lumry,et al.  Combined Salmeterol 50 μ g and Fluticasone Propionate 250 μ g in the Diskus Device for the Treatment of Asthma , 2000 .

[5]  D. Hendrick,et al.  Effect of inhaled fluticasone propionate on airway responsiveness in treatment-naive individuals--a lesser benefit in females. , 2000, The European respiratory journal.

[6]  J. Fahy,et al.  Low- and high-dose fluticasone propionate in asthma; effects during and after treatment. , 2000, The European respiratory journal.

[7]  W. Busse,et al.  Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant. , 1999, The Journal of allergy and clinical immunology.

[8]  J. Vandenbroucke,et al.  Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. , 1999, American journal of respiratory and critical care medicine.

[9]  V. Backer,et al.  Salmeterol and fluticasone propionate (50/250 microg) administered via combination Diskus inhaler: as effective as when given via separate Diskus inhalers. , 1999, Canadian respiratory journal.

[10]  S. Szefler,et al.  Dose-related efficacy of budesonide administered via a dry powder inhaler in the treatment of children with moderate to severe persistent asthma. , 1998, The Journal of pediatrics.

[11]  T L Petty,et al.  Budesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma. , 1998, The Journal of allergy and clinical immunology.

[12]  W. Busse,et al.  Efficacy and safety of inhaled corticosteroids. New developments. , 1998, American journal of respiratory and critical care medicine.

[13]  D. Postma,et al.  Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. , 1997, The New England journal of medicine.

[14]  S. Pedersen,et al.  A randomized, double-blind dose reduction study to compare the minimal effective dose of budesonide Turbuhaler and fluticasone propionate Diskhaler. , 1997, The Journal of allergy and clinical immunology.

[15]  B. Lipworth,et al.  Dose-Response of Inhaled Drugs in Asthma , 1997, Clinical pharmacokinetics.

[16]  F. Hampel,et al.  Effectiveness of fluticasone propionate in patients with moderate asthma: a dose-ranging study. , 1996, Clinical therapeutics.

[17]  Tari Haahtela,et al.  Randomised comparison of guided self management and traditional treatment of asthma over one year , 1996, BMJ.

[18]  A Pietinalho,et al.  Effect of early vs late intervention with inhaled corticosteroids in asthma. , 1995, Chest.

[19]  R. Dockhorn,et al.  Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma. The Fluticasone Propionate Asthma Study Group. , 1994, The Journal of allergy and clinical immunology.

[20]  T. Haahtela,et al.  Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. , 1994, The New England journal of medicine.

[21]  L. Boulet,et al.  Comparative safety and efficacy of single or twice daily administration of inhaled beclomethasone in moderate asthma. , 1994, Chest.

[22]  C. G. Langdon,et al.  Pulmicort Turbohaler once daily as initial prophylactic therapy for asthma. , 1994, Respiratory medicine.

[23]  P. Howarth,et al.  Inhaled beclomethasone dipropionate downregulates airway lymphocyte activation in atopic asthma. , 1994, American journal of respiratory and critical care medicine.

[24]  R. Dahl,et al.  A Dose-Ranging Study of Fluticasone Propionate in Adult Patients With Moderate Asthma , 1993 .

[25]  L. Lehtonen,et al.  Comparison of oral-steroid sparing by high-dose and low-dose inhaled steroid in maintenance treatment of severe asthma , 1992, The Lancet.

[26]  T. Haahtela,et al.  A comparative study of the effects of an inhaled corticosteroid, budesonide, and a beta 2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: a randomized, double-blind, parallel-group controlled trial. , 1992, The Journal of allergy and clinical immunology.

[27]  R. Dahl,et al.  A double‐blind dose‐response study of budesonide by inhalation in patients with bronchial asthma , 1988, Allergy.

[28]  K. Palmer,et al.  Aerosol beclomethasone dipropionate: a dose-response study in chronic bronchial asthma. , 1973, Lancet.